Cipher PharmaceuticalsCipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products ProductsPipeline NewsCipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant to its Normal Course Issuer Bid March 25, 2021Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results March 18, 2021Events Q1 2020 Results Conference Call/Webcast Friday, May 8, 2020 Webcast Replay Investors Financial Reports Investor Presentation Corporate Governance Documents Webcasts
